Literature DB >> 35999475

Assessment of mechanism involved in the apoptotic and anti-cancer activity of Quercetin and Quercetin-loaded chitosan nanoparticles.

Murat Dogan1.   

Abstract

In prior studies, Quercetin was revealed to exhibit anti-cancer features in a variety of cancer cell lines. However, the impact of Quercetin on neuroblastoma is unknown. This study looked into the potential cytotoxic effects of Quercetin and Quercetin-loaded chitosan nanoparticles (NPs) on the SH-SY5Y cell line. In this study, NPs containing Quercetin was prepared and characterization studies were performed. The vitality of the cells was measured using the XTT test after 24 h of treatment with various concentrations of Quercetin (0.5, 1, 2, 4, and 8 µg/mL). ELISA kits were used to detect the amounts of cleaved PARP, BCL-2, 8-Hydroxy-deoxyguanosine (8-oxo-dG), cleaved caspase 3, Bax, total oxidant status, and total antioxidant status in the cells. The results of the chitosan NPs characterization investigation revealed that the particle size, encapsulation effectiveness, and drug release profile of NPs were all appropriate for cell culture studies. Quercetin and Quercetin-loaded chitosan NPs significantly reduced cell viability in SH-SY5Y cells at different concentrations (**p < 0.05). 2 µg/mL Quercetin and Quercetin-loaded chitosan NPs significantly enhanced the levels of 8-oxo-dG, cleaved caspase 3, Bax, cleaved PARP, and total oxidant in ELISA testing. However, treatment with 2 µg/mL of Quercetin and Quercetin-loaded chitosan NPs did not affect the amount of BCL-2 protein. Overall, Quercetin and Quercetin-loaded chitosan NPs caused significant cytotoxicity in SH-SY5Y cells via producing oxidative stress, DNA damage, and eventually apoptosis.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Apoptosis; DNA damage; ELISA; Quercetin; Quercetin-loaded chitosan NPs; SH-SY5Y cell

Mesh:

Substances:

Year:  2022        PMID: 35999475     DOI: 10.1007/s12032-022-01820-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.738


  6 in total

Review 1.  Immunological aspects of cancer chemotherapy.

Authors:  Laurence Zitvogel; Lionel Apetoh; François Ghiringhelli; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

2.  In vitro and in vivo effects of chitosan-praziquantel and chitosan-albendazole nanoparticles on Echinococcus granulosus Metacestodes.

Authors:  Negin Torabi; Faramarz Dobakhti; Soghrat Faghihzadeh; Ali Haniloo
Journal:  Parasitol Res       Date:  2018-04-03       Impact factor: 2.289

Review 3.  Chitosan-based hydrogels for controlled, localized drug delivery.

Authors:  Narayan Bhattarai; Jonathan Gunn; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2009-09-30       Impact factor: 15.470

4.  Immunohistochemical expression of TGF beta (TGF-β), TGF beta receptor 1 (TGFBR1), and Ki67 in intestinal variant of gastric adenocarcinomas.

Authors:  Anca Oana Docea; P Mitruţ; Diana Grigore; D Pirici; Daniela Cornelia Călina; Eliza Gofiţă
Journal:  Rom J Morphol Embryol       Date:  2012       Impact factor: 1.033

5.  Modulation of G2/M cell cycle arrest and apoptosis by luteolin in human colon cancer cells and xenografts.

Authors:  Zhicheng Chen; Bo Zhang; Feng Gao; Renjie Shi
Journal:  Oncol Lett       Date:  2017-11-23       Impact factor: 2.967

Review 6.  New opportunities for nanoparticles in cancer immunotherapy.

Authors:  Wooram Park; Young-Jae Heo; Dong Keun Han
Journal:  Biomater Res       Date:  2018-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.